BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29073352)

  • 1. Accumulation of Antigen-Driven Lymphoproliferations in Complement Receptor 2/CD21
    Glauzy S; Boccitto M; Bannock JM; Delmotte FR; Saadoun D; Cacoub P; Ice JA; Sivils KL; James JA; Wolin SL; Meffre E
    Arthritis Rheumatol; 2018 Feb; 70(2):298-307. PubMed ID: 29073352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expansion of autoreactive unresponsive CD21-/low B cells in Sjögren's syndrome-associated lymphoproliferation.
    Saadoun D; Terrier B; Bannock J; Vazquez T; Massad C; Kang I; Joly F; Rosenzwajg M; Sene D; Benech P; Musset L; Klatzmann D; Meffre E; Cacoub P
    Arthritis Rheum; 2013 Apr; 65(4):1085-96. PubMed ID: 23279883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective Early B Cell Tolerance Checkpoints in Sjögren's Syndrome Patients.
    Glauzy S; Sng J; Bannock JM; Gottenberg JE; Korganow AS; Cacoub P; Saadoun D; Meffre E
    Arthritis Rheumatol; 2017 Nov; 69(11):2203-2208. PubMed ID: 28704602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary gland B cell lymphoproliferative disorders in Sjögren's syndrome present a restricted use of antigen receptor gene segments similar to those used by hepatitis C virus-associated non-Hodgkins's lymphomas.
    De Re V; De Vita S; Gasparotto D; Marzotto A; Carbone A; Ferraccioli G; Boiocchi M
    Eur J Immunol; 2002 Mar; 32(3):903-10. PubMed ID: 11870635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell receptor repertoire in B cell lymphoproliferative lesions in primary Sjögren's syndrome.
    Pivetta B; De Vita S; Ferraccioli G; De Re V; Gloghini A; Marzotto A; Caruso G; Dolcetti R; Bartoli E; Carbone A; Boiocchi M
    J Rheumatol; 1999 May; 26(5):1101-9. PubMed ID: 10332975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD27
    Wilbrink R; Spoorenberg A; Arends S; van der Geest KSM; Brouwer E; Bootsma H; Kroese FGM; Verstappen GM
    Front Immunol; 2021; 12():686273. PubMed ID: 34168654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of self-reactive naïve and memory B cell reveals sequential defects in B cell tolerance checkpoints in Sjögren's syndrome.
    Corsiero E; Sutcliffe N; Pitzalis C; Bombardieri M
    PLoS One; 2014; 9(12):e114575. PubMed ID: 25535746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjögren's syndrome.
    Hansen A; Odendahl M; Reiter K; Jacobi AM; Feist E; Scholze J; Burmester GR; Lipsky PE; Dörner T
    Arthritis Rheum; 2002 Aug; 46(8):2160-71. PubMed ID: 12209521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjögren's syndrome.
    De Vita S; Boiocchi M; Sorrentino D; Carbone A; Avellini C; Dolcetti R; Marzotto A; Gloghini A; Bartoli E; Beltrami CA; Ferraccioli G
    Arthritis Rheum; 1997 Feb; 40(2):318-31. PubMed ID: 9041944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of Alternative Modes of B Cell Activation Involving Acquired Fab Regions of N-Glycosylation in Antibody-Secreting Cells Infiltrating the Labial Salivary Glands of Patients With Sjögren's Syndrome.
    Koelsch KA; Cavett J; Smith K; Moore JS; Lehoux SD; Jia N; Mather T; Quadri SMS; Rasmussen A; Kaufman CE; Lewis DM; Radfar L; Scordino TA; Lessard CJ; Kurien BT; Cummings RD; James JA; Sivils KL; Farris AD; Scofield RH
    Arthritis Rheumatol; 2018 Jul; 70(7):1102-1113. PubMed ID: 29457375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of the B-cell-regulatory molecule CD72 in primary Sjögren's syndrome.
    Smith AJ; Gordon TP; Macardle PJ
    Tissue Antigens; 2004 Mar; 63(3):255-9. PubMed ID: 14989715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulation of chemokine receptor expression and function by B cells of patients with primary Sjögren's syndrome.
    Hansen A; Reiter K; Ziprian T; Jacobi A; Hoffmann A; Gosemann M; Scholze J; Lipsky PE; Dörner T
    Arthritis Rheum; 2005 Jul; 52(7):2109-19. PubMed ID: 15986367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormalities in peripheral B cell memory of patients with primary Sjögren's syndrome.
    Hansen A; Gosemann M; Pruss A; Reiter K; Ruzickova S; Lipsky PE; Dörner T
    Arthritis Rheum; 2004 Jun; 50(6):1897-908. PubMed ID: 15188366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep Phenotyping of CD11c
    Rincon-Arevalo H; Wiedemann A; Stefanski AL; Lettau M; Szelinski F; Fuchs S; Frei AP; Steinberg M; Kam-Thong T; Hatje K; Keller B; Warnatz K; Radbruch A; Lino AC; Schrezenmeier E; Dörner T
    Front Immunol; 2021; 12():635615. PubMed ID: 33777025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salivary Gland Mucosa-Associated Lymphoid Tissue-Type Lymphoma From Sjögren's Syndrome Patients in the Majority Express Rheumatoid Factors Affinity-Selected for IgG.
    Bende RJ; Janssen J; Beentjes A; Wormhoudt TAM; Wagner K; Haacke EA; Kroese FGM; Guikema JEJ; van Noesel CJM
    Arthritis Rheumatol; 2020 Aug; 72(8):1330-1340. PubMed ID: 32182401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BAFF-induced changes in B cell antigen receptor-containing lipid rafts in Sjögren's syndrome.
    d'Arbonneau F; Pers JO; Devauchelle V; Pennec Y; Saraux A; Youinou P
    Arthritis Rheum; 2006 Jan; 54(1):115-26. PubMed ID: 16385503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence and selection of an expanded B-cell clone in the setting of rituximab therapy for Sjögren's syndrome.
    Hershberg U; Meng W; Zhang B; Haff N; St Clair EW; Cohen PL; McNair PD; Li L; Levesque MC; Luning Prak ET
    Arthritis Res Ther; 2014 Feb; 16(1):R51. PubMed ID: 24517398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major immunoglobulin capping deficiency in the peripheral blood B cells of patients with Sjögren's syndrome.
    Bataille R; Zhang XG; Duperray C; Rajzbaum G; Brochier J; Klein B
    Immunology; 1992 Mar; 75(3):550-2. PubMed ID: 1572701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A CD21 low phenotype, with no evidence of autoantibodies to complement proteins, is consistent with a poor prognosis in CLL.
    Nichols EM; Jones R; Watson R; Pepper CJ; Fegan C; Marchbank KJ
    Oncotarget; 2015 Oct; 6(32):32669-80. PubMed ID: 26452134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands.
    Quartuccio L; Salvin S; Fabris M; Maset M; Pontarini E; Isola M; De Vita S
    Rheumatology (Oxford); 2013 Feb; 52(2):276-81. PubMed ID: 22879463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.